Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry.


Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
11 2023
Historique:
received: 29 12 2022
revised: 13 06 2023
accepted: 13 06 2023
medline: 6 11 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: ppublish

Résumé

The management of chronic coronary syndrome (CCS) is informed by studies predominantly including men. This study investigated the relationship between patients sex and different endotypes of CCS, including sex-specific clinical outcomes. In patients with CCS undergoing coronary angiography, invasive Fractional Flow Reserve (FFR) and Coronary Flow Reserve (CFR) were measured. Patients were stratified into groups: 1) obstructive coronary artery disease (oCAD) (FFR≤0.80, no revascularization), 2) undergoing revascularization, 3) non-obstructive coronary artery disease with coronary microvascular dysfunction (CMD) (FFR>0.80, CFR≤2.5), and 4) non-obstructive coronary artery disease without CMD (FFR>0.80 and CFR>2.5). 1836 patients (2335 vessels) were included, comprising 1359 (74.0%) men and 477 (26.0%) women. oCAD was present in 14.1% and was significantly less prevalent in women than in men (10.3% vs 15.5%, respectively p < 0.01). Revascularization was present in 30.9% and was similarly prevalent in women and men (28.2% vs. 31.9%, respectively p = 0.13). CMD was present in 24.2% and was significantly more prevalent in women than men (28.6% vs 22.6%, respectively p < 0.01). Normal invasive measurements were found in 564 patients (33.0% women vs 30.0% men, p = 0.23). Male sex was associated with an increased risk of target vessel failure compared to women (HR.1.89, 95% CI 1.12-3.18, p = 0.018), regardless of CCS-endotype. Sex differences exist in the prevalence and outcomes of different endotypes of CCS in symptomatic patients undergoing invasive coronary angiography. In particular, oCAD (and subsequent revascularization) were more prevalent in men. Conversely, CMD was more prevalent in women. Overall, men experienced a worse cardiovascular outcome compared to women, independent of any specific CCS endotype.

Sections du résumé

BACKGROUND AND AIMS
The management of chronic coronary syndrome (CCS) is informed by studies predominantly including men. This study investigated the relationship between patients sex and different endotypes of CCS, including sex-specific clinical outcomes.
METHODS
In patients with CCS undergoing coronary angiography, invasive Fractional Flow Reserve (FFR) and Coronary Flow Reserve (CFR) were measured. Patients were stratified into groups: 1) obstructive coronary artery disease (oCAD) (FFR≤0.80, no revascularization), 2) undergoing revascularization, 3) non-obstructive coronary artery disease with coronary microvascular dysfunction (CMD) (FFR>0.80, CFR≤2.5), and 4) non-obstructive coronary artery disease without CMD (FFR>0.80 and CFR>2.5).
RESULTS
1836 patients (2335 vessels) were included, comprising 1359 (74.0%) men and 477 (26.0%) women. oCAD was present in 14.1% and was significantly less prevalent in women than in men (10.3% vs 15.5%, respectively p < 0.01). Revascularization was present in 30.9% and was similarly prevalent in women and men (28.2% vs. 31.9%, respectively p = 0.13). CMD was present in 24.2% and was significantly more prevalent in women than men (28.6% vs 22.6%, respectively p < 0.01). Normal invasive measurements were found in 564 patients (33.0% women vs 30.0% men, p = 0.23). Male sex was associated with an increased risk of target vessel failure compared to women (HR.1.89, 95% CI 1.12-3.18, p = 0.018), regardless of CCS-endotype.
CONCLUSIONS
Sex differences exist in the prevalence and outcomes of different endotypes of CCS in symptomatic patients undergoing invasive coronary angiography. In particular, oCAD (and subsequent revascularization) were more prevalent in men. Conversely, CMD was more prevalent in women. Overall, men experienced a worse cardiovascular outcome compared to women, independent of any specific CCS endotype.

Identifiants

pubmed: 37558604
pii: S0021-9150(23)04090-X
doi: 10.1016/j.atherosclerosis.2023.06.073
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT04485234']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117167

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Caitlin E M Vink (CEM)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands.

Janneke Woudstra (J)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands.

Joo Myung Lee (JM)

Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Coen K M Boerhout (CKM)

Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands.

Christopher M Cook (CM)

The Essex Cardiothoracic Centre, Essex, United Kingdom; Anglia Ruskin University, Essex, United Kingdom.

Masahiro Hoshino (M)

Gifu Heart Center, Department of Cardiovascular Medicine, Gifu, Japan.

Hernan Mejia-Renteria (H)

Hospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.

Seung Hun Lee (SH)

Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.

Ji-Hyun Jung (JH)

Sejong General Hospital, Sejong Heart Institute, Bucheon, Republic of Korea.

Mauro Echavarria-Pinto (M)

Hospital General ISSSTE Querétaro - Facultad de Medicina, Universidad Autónoma de Querétaro, Querétaro, Mexico.

Martijn Meuwissen (M)

Department of Cardiology, Amphia Hospital, Breda, the Netherlands.

Hitoshi Matsuo (H)

Sejong General Hospital, Sejong Heart Institute, Bucheon, Republic of Korea.

Maribel Madera-Cambero (M)

Tergooi Hospital, Department of Cardiology, Blaricum, the Netherlands.

Ashkan Eftekhari (A)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Mohamed A Effat (MA)

Division of Cardiovascular Health and Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, USA.

Tadashi Murai (T)

Tsuchiura Kyodo General Hospital, Department of Cardiology, Tsuchiura City, Japan.

Koen Marques (K)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands.

Marcel A M Beijk (MAM)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands.

Joon-Hyung Doh (JH)

Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.

Jan J Piek (JJ)

Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands.

Tim P van de Hoef (TP)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands; Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.

Evald Høj Christiansen (EH)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Rupak Banerjee (R)

Mechanical and Materials Engineering Department, University of Cincinnati, Cincinnati, OH, USA; Research Services, Veteran Affairs Medical Center, Cincinnati, OH, USA.

Chang-Wook Nam (CW)

Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.

Giampaolo Niccoli (G)

Department of Cardiovascular Medicine, Catholic University of the Sacred Heart, Institute of Cardiology, Rome, Italy.

Masafumi Nakayama (M)

Sejong General Hospital, Sejong Heart Institute, Bucheon, Republic of Korea; Cardiovascular Center, Toda Central General Hospital, Toda, Japan.

Nobuhiro Tanaka (N)

Department of Cardiology, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan.

Eun-Seok Shin (ES)

Department of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

Niels van Royen (N)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Steven A J Chamuleau (SAJ)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands.

Paul Knaapen (P)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam UMC - Location AMC, Amsterdam, the Netherlands.

Javier Escaned (J)

Hospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.

Tsunekazu Kakuta (T)

Tsuchiura Kyodo General Hospital, Department of Cardiology, Tsuchiura City, Japan.

Bon-Kwon Koo (BK)

Department of Internal Medicine, Seoul National University Hospital, Cardiovascular Center, Seoul, Republic of Korea.

Yolande Appelman (Y)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands.

Guus A de Waard (GA)

Department of Cardiology, Amsterdam UMC - Location VUmc, Amsterdam, the Netherlands. Electronic address: g.dewaard@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH